MARINUS PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Marinus Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2013 to Q3 2024.
  • Marinus Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 55.2M shares, a 1.12% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 55.2M +612K +1.12% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 55M +4.35M +8.61% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 54.9M +5.27M +10.6% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 54.6M +4.94M +9.94% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 54.6M +17.4M +46.7% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 50.6M +13.4M +36% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 49.7M +12.5M +33.7% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 49.6M +12.9M +34.9% Dec 31, 2022 10-K 2024-03-05
Q3 2022 37.2M +445K +1.21% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 37.2M +467K +1.27% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 37.1M +505K +1.38% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 36.8M +212K +0.58% Dec 31, 2021 10-K 2023-03-09
Q3 2021 36.8M +6.18M +20.2% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 36.7M -85.5M -69.9% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 36.6M -50.1M -57.8% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 36.6M +15M +69.2% Dec 31, 2020 10-K 2022-03-24
Q3 2020 30.6M -22M -41.8% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 122M +69.6M +133% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 86.7M +34.2M +65% Mar 31, 2020 10-Q 2020-05-04
Q4 2019 21.6M -30.9M -58.8% Dec 31, 2019 10-K 2021-03-09
Q3 2019 52.6M +12.1M +29.7% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 52.6M +12M +29.7% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 52.6M +12M +29.7% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 52.5M +12M +29.6% Dec 31, 2018 10-K 2020-03-16
Q3 2018 40.5M +94.8K +0.24% Sep 30, 2018 10-Q 2018-10-29
Q2 2018 40.5M +18.1M +80.8% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 40.5M +18.6M +84.8% Mar 31, 2018 10-Q 2018-05-02
Q4 2017 40.5M +20.8M +106% Dec 31, 2017 10-K 2019-03-12
Q3 2017 40.4M +20.7M +105% Sep 30, 2017 10-Q 2017-10-31
Q2 2017 22.4M +2.91M +14.9% Jun 30, 2017 10-Q 2017-08-01
Q1 2017 21.9M +2.42M +12.4% Mar 31, 2017 10-Q 2017-05-01
Q4 2016 19.7M +314K +1.62% Dec 31, 2016 10-K 2018-03-07
Q3 2016 19.7M +5.37M +37.5% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 19.5M +5.28M +37.1% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 19.5M +5.31M +37.4% Mar 31, 2016 10-Q 2016-05-02
Q4 2015 19.4M +5.38M +38.4% Dec 31, 2015 10-K 2017-03-13
Q3 2015 14.3M +423K +3.04% Sep 30, 2015 10-Q 2015-10-29
Q2 2015 14.2M +13.7M +2792% Jun 30, 2015 10-Q 2015-08-04
Q1 2015 14.2M Mar 31, 2015 10-Q 2015-05-14
Q4 2014 14M +13.5M +2912% Dec 31, 2014 10-K 2016-03-07
Q3 2014 13.9M Sep 30, 2014 10-Q 2014-11-13
Q2 2014 492K Jun 30, 2014 10-Q/A 2014-10-10
Q4 2013 465K Dec 31, 2013 10-K 2015-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.